Lumos Pharma Inc (LUMO)
4.32
+0.02
(+0.47%)
USD |
NASDAQ |
Nov 14, 12:38
Lumos Pharma Shareholders Equity (Quarterly): 10.28M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 10.28M |
March 31, 2024 | 17.44M |
December 31, 2023 | 27.30M |
September 30, 2023 | 35.49M |
June 30, 2023 | 43.66M |
March 31, 2023 | 52.52M |
December 31, 2022 | 59.58M |
September 30, 2022 | 67.71M |
June 30, 2022 | 74.55M |
March 31, 2022 | 81.82M |
December 31, 2021 | 88.98M |
September 30, 2021 | 94.12M |
June 30, 2021 | 101.12M |
March 31, 2021 | 108.97M |
December 31, 2020 | 116.57M |
September 30, 2020 | 118.54M |
June 30, 2020 | 116.46M |
March 31, 2020 | 121.54M |
December 31, 2019 | -59.46M |
September 30, 2019 | 86.40M |
June 30, 2019 | 98.69M |
March 31, 2019 | 107.02M |
December 31, 2018 | 115.14M |
September 30, 2018 | 122.20M |
June 30, 2018 | 124.95M |
Date | Value |
---|---|
March 31, 2018 | 137.95M |
December 31, 2017 | 151.56M |
September 30, 2017 | 106.46M |
June 30, 2017 | 102.60M |
March 31, 2017 | 114.35M |
December 31, 2016 | 129.47M |
September 30, 2016 | 138.28M |
June 30, 2016 | 149.34M |
March 31, 2016 | 176.81M |
December 31, 2015 | 195.77M |
September 30, 2015 | 207.41M |
June 30, 2015 | 225.76M |
March 31, 2015 | 232.83M |
December 31, 2014 | 196.94M |
September 30, 2014 | 70.39M |
June 30, 2014 | 72.60M |
March 31, 2014 | 79.82M |
December 31, 2013 | 58.33M |
September 30, 2013 | 47.35M |
June 30, 2013 | 54.36M |
March 31, 2013 | 59.99M |
December 31, 2012 | 17.93M |
September 30, 2012 | 23.22M |
June 30, 2012 | 28.23M |
March 31, 2012 | 32.80M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-59.46M
Minimum
Dec 2019
121.54M
Maximum
Mar 2020
67.22M
Average
74.55M
Median
Jun 2022
Shareholders Equity (Quarterly) Benchmarks
Boston Scientific Corp | 20.71B |
Calidi Biotherapeutics Inc | -11.75M |
NovaBay Pharmaceuticals Inc | -0.617M |
Palatin Technologies Inc | -0.1115M |
iBio Inc | 21.32M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 21.36M |
Total Liabilities (Quarterly) | 11.08M |
Current Ratio | 4.233 |